Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Titel:
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Auteur:
Fizazi, Karim Carducci, Michael Smith, Matthew Damião, Ronaldo Brown, Janet Karsh, Lawrence Milecki, Piotr Shore, Neal Rader, Michael Wang, Huei Jiang, Qi Tadros, Sylvia Dansey, Roger Goessl, Carsten